TREA

Algal elongase 6

Follow

Information

  • Patent Grant
  • 9783812
  • Patent Number
    9,783,812
  • Date Filed
    Monday, October 12, 2015
    8 years ago
  • Date Issued
    Tuesday, October 10, 2017
    6 years ago
Information
Abstract
Provided herein are exemplary isolated nucleotide sequences encoding polypeptides having elongase activity, which utilize fatty acids as substrates.
Description
REFERENCE TO SEQUENCE LISTINGS

The present application is filed with sequence listing(s) attached hereto and incorporated by reference.


BACKGROUND OF THE INVENTION
Field of the Invention

This invention relates to molecular biology, and more specifically, to algal elongases.


SUMMARY OF THE INVENTION

Isolated nucleotide sequences encoding polypeptides having elongase activity, which utilize fatty acids as substrates.


In a first aspect, this disclosure provides a vector comprising a polynucleotide sequence encoding elongase 6 having the amino acid sequence of SEQ ID NO:14. In some embodiments, the polynucleotide sequence is SEQ ID NO:6. In some embodiments, the vector further comprises a Violaxanthin-chlorophyll a binding protein (VCP) promoter. In some embodiments, the vector is a transformation vector or a homologous recombination vector. In some embodiments, the vector has been incorporated into the genome of an algal cell.


In a second aspect, this disclosure provides a transformed algal cell with increased or decreased poly unsaturated fatty acid biosynthesis, as the algal cell has, respectively, enhanced or suppressed expression level of elongase 6 having the amino acid sequence of SEQ ID NO:14, The algal cell is further defined in that: the enhanced expression is by replacement of an endogenous promoter with a strong promoter in front of a gene encoding said elongase 6, whereas the suppressed expression may be by (1) replacement of an endogenous promoter with a weak promoter in front of a gene encoding said elongase 6, or (2) an insertion in a gene encoding said elongase 6, and a deletion or a substitution of a portion or the full length of a gene encoding said elongase 6. In some embodiments, the algal cell is a knock-out mutant of the elongase 6. In other embodiments, the algal cell is Nannochloropsis, such as Nannochloropsis oceanica.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 illustrates the nucleotide sequence encoding elongase 1 (SEQ ID NO:1).



FIG. 2 illustrates the nucleotide sequence encoding elongase 2 (SEQ ID NO:2).



FIG. 3 illustrates the nucleotide sequence encoding elongase 3 (SEQ ID NO:3).



FIG. 4 illustrates the nucleotide sequence encoding elongase 4 (SEQ ID NO:4).



FIG. 5 illustrates the nucleotide sequence encoding elongase 5 (SEQ ID NO:5).



FIG. 6 illustrates the nucleotide sequence encoding elongase 6 (SEQ ID NO:6).



FIG. 7 illustrates the nucleotide sequence encoding elongase 7 (SEQ ID NO:7).



FIG. 8 illustrates the nucleotide sequence encoding elongase 8 (SEQ ID NO:8).



FIG. 9 illustrates the amino acid sequence encoding elongase 1 (SEQ ID NO:9).



FIG. 10 illustrates the amino acid sequence encoding elongase 2 (SEQ ID NO:10).



FIG. 11 illustrates the amino acid sequence encoding elongase 3 (SEQ ID NO:11).



FIG. 12 illustrates the amino acid sequence encoded by elongase 4 (SEQ ID NO:12).



FIG. 13 illustrates the amino acid sequence encoded by elongase 5 (SEQ ID NO:13).



FIG. 14 illustrates the amino acid sequence encoded by elongase 6 (SEQ ID NO:14).



FIG. 15 illustrates the amino acid sequence encoded by elongase 7 (SEQ ID NO:15).



FIG. 16 illustrates the amino acid sequence encoded by elongase 8 (SEQ ID NO:16).





DETAILED DESCRIPTION OF THE INVENTION

A fatty acid is a carboxylic acid with a long aliphatic tail (chain), which is either saturated or unsaturated. Saturated fatty acids are long-chain carboxylic acids that usually have between 12 and 24 carbon atoms and have no double bonds. Unsaturated fatty acids have one or more double bonds between carbon atoms. Most naturally occurring fatty acids have a chain of an even number of carbon atoms, from 4 to 28. Elongases are enzymes which lengthen fatty acids by adding two carbon atoms to a fatty acid's carboxylic acid end.


Provided herein are isolated nucleotide sequences encoding polypeptides having elongase activity, which utilize fatty acids as substrates.


The inventors sequenced the entire genome of algal genus Nannochloropsis and identified genes involved in fatty acid metabolism. They identified various elongases, including exemplary elongases which they designated as elongases 1-9.


The inventors manipulated the activities of the above-specified exemplary elongase genes by:


1. Overexpression of the subject elongase gene with a strong promoter.


2. Promoter replacement or promoter insertion in front of the subject elongase gene within the genome via homologous recombination.


3. Knock out of the subject elongase gene via insertion of a transformation construct into the gene or replacement of a part of or the entire subject elongase gene via homologous recombination.


Exemplary support for the above-mentioned methods may be found in U.S. Non-Provisional patent application Ser. No. 12/581,812 filed on Oct. 19, 2009, titled “Homologous Recombination in an Algal Nuclear Genome,” now U.S. Pat. No. 8,865,468, U.S. Non-Provisional patent application Ser. No. 12/480,635 filed on Jun. 8, 2009, titled “VCP-Based Vectors for Algal Cell Transformation,” now U.S. Pat. No. 8,318,482, and U.S. Non-Provisional patent application Ser. No. 12/480,611 filed on Jun. 8, 2009, titled “Transformation of Algal Cells,” now U.S. Pat. No. 8,119,859, all of which are hereby incorporated by reference.


Accordingly, the inventors were able to manipulate the activities of the various exemplary elongases for the purpose of modifying the contents of certain fatty acids within algal genus Nannochloropsis.


Some of these elongases, i.e. Elongases 6-8, are down-regulated under conditions when poly unsaturated fatty acid (“PUFA”) biosynthesis is down-regulated as well (i.e. during Nitrogen starvation). These genes are excellent targets for over-expression, in order to achieve elevated PUFA biosynthesis. Down-regulation of these (or other) genes, as an example, by replacement of the endogenous promoter or insertion of a weaker promoter in front of the respective elongase gene could lead to a higher content of short chain fatty acids. Down-regulation of transcription could also be achieved, in some cases, by insertion of a commonly strong promoter in front of the respective elongase gene, presumably by modifying the respective chromatin arrangement around the said elongase gene, thus leading to a lower transcription level. Also, the introduction of point mutations into the gene when inserting another promoter in front of such a gene via the homologous recombination flanks utilized, could lead to an altered activity of the respective gene products.


Over expression and knock out mutants of said elongase genes suggest that at least 4 elongases with overlapping functions are operating in the biosynthesis pathway leading to Eicosapentaenoic acid (“EPA”): these are, but not limited to: Elongases 5, 6, 7, and 9. Transcriptome analysis also suggests that Elongase 8 is operating as well in the fatty acid biosynthesis pathway to EPA.



FIG. 1 illustrates the nucleotide sequence encoding elongase 1 (SEQ ID NO:1).



FIG. 2 illustrates the nucleotide sequence encoding elongase 2 (SEQ ID NO:2).



FIG. 3 illustrates the nucleotide sequence encoding elongase 3 (SEQ ID NO:3).



FIG. 4 illustrates the nucleotide sequence encoding elongase 4 (SEQ ID NO:4).



FIG. 5 illustrates the nucleotide sequence encoding elongase 5 (SEQ ID NO:5).



FIG. 6 illustrates the nucleotide sequence encoding elongase 6 (SEQ ID NO:6).



FIG. 7 illustrates the nucleotide sequence encoding elongase 7 (SEQ ID NO:7).



FIG. 8 illustrates the nucleotide sequence encoding elongase 8 (SEQ ID NO:8).



FIG. 9 illustrates the amino acid sequence encoding elongase 1 (SEQ ID NO:9).



FIG. 10 illustrates the amino acid sequence encoding elongase 2 (SEQ ID NO:10).



FIG. 11 illustrates the amino acid sequence encoding elongase 3 (SEQ ID NO:11).



FIG. 12 illustrates the amino acid sequence encoded by elongase 4 (SEQ ID NO:12).



FIG. 13 illustrates the amino acid sequence encoded by elongase 5 (SEQ ID NO:13).



FIG. 14 illustrates the amino acid sequence encoded by elongase 6 (SEQ ID NO:14).



FIG. 15 illustrates the amino acid sequence encoded by elongase 7 (SEQ ID NO:15).



FIG. 16 illustrates the amino acid sequence encoded by elongase 8 (SEQ ID NO:16).


While various embodiments have been described above, it should be understood that they have been presented by way of example only, and not limitation. Thus, the breadth and scope of a preferred embodiment should not be limited by any of the above-described exemplary embodiments.

Claims
  • 1. A transformation vector comprising a polynucleotide sequence encoding a polypeptide having elongase 6 activity and comprises the amino acid sequence of SEQ ID NO: 14.
  • 2. The transformation vector of claim 1, wherein the said polynucleotide sequence comprises the nucleotide sequence of SEQ ID NO: 6.
  • 3. The transformation vector of claim 1, further comprising a Violaxanthin-chlorophyll a binding protein (VCP) promoter.
  • 4. The transformation vector of claim 1, wherein said transformation vector has been incorporated into the genome of an algal cell.
  • 5. A transformed algal cell with increased or decreased poly unsaturated fatty acid biosynthesis, wherein said transformed algal cell has, respectively, enhanced or suppressed expression level of elongase 6 comprising the amino acid sequence of SEQ ID NO: 14, wherein said enhanced expression comprises replacement of an endogenous promoter with a strong promoter in front of a gene encoding said elongase 6 comprising the amino acid sequence of SEQ ID NO: 14,wherein said suppressed expression is selected from the group consisting of replacement of an endogenous promoter with a weak promoter in front of a gene encoding said elongase 6, an insertion in a gene encoding said elongase 6, and a deletion or a substitution of a portion or the full length of a gene encoding said elongase 6 comprising the amino acid sequence of SEQ ID NO: 14,wherein said strong promoter is stronger than said endogenous promoter and said weak promoter is weaker than said endogenous promoter.
  • 6. The transformed algal cell of claim 5, wherein said transformed algal cell comprises a knock-out mutant of said elongase 6.
  • 7. The transformed algal cell of claim 5, wherein said transformed algal cell is a Nannochloropsis cell.
  • 8. The transformed algal cell of claim 7, wherein said Nannochloropsis cell is Nannochloropsis oceanica.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a division of U.S. patent application Ser. No. 14/328,463, filed Jul. 10, 2014, now U.S. Pat. No. 9,376,687, which is a continuation of U.S. patent application Ser. No. 13/459,215, filed Apr. 12, 2012, now U.S. Pat. No. 8,809,046, which claims the benefit and priority of U.S. Patent Provisional Application Ser. No. 61/480,364 filed Apr. 28, 2011, titled “Elongases,” which is hereby incorporated by reference. The present application is related to U.S. Non-Provisional patent application Ser. No. 12/581,812 filed on Oct. 19, 2009, titled “Homologous Recombination in an Algal Nuclear Genome,” now U.S. Pat. No. 8,865,468, which is hereby incorporated by reference. The present application is related to U.S. Non-Provisional patent application Ser. No. 12/480,635 filed on Jun. 8, 2009, titled “VCP-Based Vectors for Algal Cell Transformation,” now U.S. Pat. No. 8,318,482, which is hereby incorporated by reference. The present application is related to U.S. Non-Provisional patent application Ser. No. 12/480,611 filed on Jun. 8, 2009, titled “Transformation of Algal Cells,” now U.S. Pat. No. 8,119,859, which is hereby incorporated by reference.

US Referenced Citations (97)
Number Name Date Kind
1926780 Lippincott Sep 1933 A
3468057 Buisson et al. Sep 1969 A
3962466 Nakabayashi Jun 1976 A
4003337 Moore Jan 1977 A
4267038 Thompson May 1981 A
4365938 Wariner Dec 1982 A
4535060 Comai Aug 1985 A
4658757 Cook Apr 1987 A
5105085 McGuire et al. Apr 1992 A
5478208 Kasai et al. Dec 1995 A
5527456 Jensen Jun 1996 A
5661017 Dunahay et al. Aug 1997 A
5668298 Waldron Sep 1997 A
5723595 Thompson et al. Mar 1998 A
5823781 Hitchcock et al. Oct 1998 A
6027900 Allnutt et al. Feb 2000 A
6117313 Goldman et al. Sep 2000 A
6143562 Trulson et al. Nov 2000 A
6166231 Hoeksema Dec 2000 A
6297054 Maliga et al. Oct 2001 B1
6372460 Gladue et al. Apr 2002 B1
6448055 Shimizu et al. Sep 2002 B1
6736572 Geraghty May 2004 B2
6750048 Ruecker et al. Jun 2004 B2
6831040 Unkefer et al. Dec 2004 B1
6871195 Ryan et al. Mar 2005 B2
7244609 Drocourt et al. Jul 2007 B2
7381326 Haddas Jun 2008 B2
7410637 Sayre et al. Aug 2008 B2
7449568 Fukuda et al. Nov 2008 B2
7547551 Schuler et al. Jun 2009 B2
8039230 Otte et al. Oct 2011 B2
8119859 Vick et al. Feb 2012 B2
8314228 Kilian et al. Nov 2012 B2
8318482 Vick et al. Nov 2012 B2
8440805 Kilian et al. May 2013 B2
20030049720 Hoshino Mar 2003 A1
20030140021 Ryan et al. Jul 2003 A1
20030143743 Schuler et al. Jul 2003 A1
20030199490 Antoni-Zimmermann Oct 2003 A1
20030211089 Sayre et al. Nov 2003 A1
20040161364 Carlson Aug 2004 A1
20040262219 Jensen Dec 2004 A1
20050064577 Berzin Mar 2005 A1
20050095569 Franklin May 2005 A1
20050124010 Short et al. Jun 2005 A1
20050170479 Weaver et al. Aug 2005 A1
20050181345 Bradbury et al. Aug 2005 A1
20050260553 Berzin Nov 2005 A1
20060031087 Fox et al. Feb 2006 A1
20060044259 Hotelling et al. Mar 2006 A1
20060045750 Stiles Mar 2006 A1
20060101535 Forster et al. May 2006 A1
20060122410 Fichtali et al. Jun 2006 A1
20060155558 Corpening Jul 2006 A1
20060166243 Su et al. Jul 2006 A1
20060166343 Hankamer et al. Jul 2006 A1
20060192690 Philipp Aug 2006 A1
20070178451 Deng et al. Aug 2007 A1
20080118964 Huntley et al. May 2008 A1
20080120749 Melis et al. May 2008 A1
20080160591 Willson et al. Jul 2008 A1
20080194029 Hegemann et al. Aug 2008 A1
20080268539 Singh et al. Oct 2008 A1
20080293132 Goldman et al. Nov 2008 A1
20090029445 Eckelberry et al. Jan 2009 A1
20090061493 Trimbur et al. Mar 2009 A1
20090061928 Lee et al. Mar 2009 A1
20090148931 Wilkerson et al. Jun 2009 A1
20090234146 Cooney et al. Sep 2009 A1
20090317857 Vick et al. Dec 2009 A1
20090317878 Champagne et al. Dec 2009 A1
20090317904 Vick et al. Dec 2009 A1
20090319338 Parks et al. Dec 2009 A1
20090325270 Vick et al. Dec 2009 A1
20100022393 Vick Jan 2010 A1
20100068772 Downey Mar 2010 A1
20100100520 Dargue et al. Apr 2010 A1
20100198659 Meltzer et al. Aug 2010 A1
20100210003 King et al. Aug 2010 A1
20100210832 Kilian et al. Aug 2010 A1
20100314324 Rice et al. Dec 2010 A1
20100323387 Bailey et al. Dec 2010 A1
20100330643 Kilian et al. Dec 2010 A1
20110015415 Singh et al. Jan 2011 A1
20110059495 Bailey et al. Mar 2011 A1
20110091977 Kilian et al. Apr 2011 A1
20120107801 Kilian et al. May 2012 A1
20120190115 Kilian et al. Jul 2012 A1
20120208279 Vick et al. Aug 2012 A1
20120277418 Kilian et al. Nov 2012 A1
20130078716 Vick et al. Mar 2013 A1
20130102040 Radakovits et al. Apr 2013 A1
20130131330 Kilian et al. May 2013 A1
20130281683 Kilian et al. Oct 2013 A1
20130289262 Kilian et al. Oct 2013 A1
20130295665 Kilian et al. Nov 2013 A1
Foreign Referenced Citations (28)
Number Date Country
1627764 Jun 2005 CN
1867140 Nov 2006 CN
1956335 May 2007 CN
101289659 Oct 2008 CN
102164492 Aug 2011 CN
102858980 Jan 2013 CN
2297326 Mar 2011 EP
2491124 Aug 2012 EP
2297326 Nov 2013 EP
1175201 Jun 2013 HK
312013 Aug 2013 IN
372013 Sep 2013 IN
2011000934 Jul 2011 MX
WO2007084078 Jul 2007 WO
WO2008060571 May 2008 WO
WO2008060571 May 2008 WO
WO2008106803 Sep 2008 WO
WO2008060571 Nov 2008 WO
WO2009124070 Oct 2009 WO
WO2009149465 Dec 2009 WO
WO2009149470 Dec 2009 WO
WO2010011335 Jan 2010 WO
WO2010147662 Dec 2010 WO
WO2011011463 Jan 2011 WO
WO2011049995 Apr 2011 WO
WO2004106238 Dec 2011 WO
WO2012149457 Nov 2012 WO
WO2013166065 Nov 2013 WO
Non-Patent Literature Citations (82)
Entry
Renaud SM et al. Effect of light intensity on the proximate biochemical and fatty acid composition of Isochrysis sp. and Nannochloropsis oculata for use in tropical aquaculture. 1991. Journal of Applied Phycology. 3:43-53.
Santin-Montanya, I. “Optimal Growth of Dunaliella Primolecta in Axenic Conditions to Assay Herbicides,” Chemosphere, 66, Elsevier 2006, p. 1315-1322.
Felix, R. “Use of the cell wall-less alga Dunaliella bioculata in herbicide screening tests,” Annals of Applied Biology, 113, 1988, pp. 55-60.
Janssen, M. “Phytosynthetic efficiency of Dunaliella tertiolecta under short light/dark cycles,” Enzyme and Microbial Technology, 29, 2001, p. 298-305.
Saenz, M.E., “Effects of Technical Grade and a Commercial Formulation of Glyphosate on Algal Population Growth,” Bulletin of Environmental Contamination Toxicology, 1997, 59: pates 638-644.
Christy et al., “Effects of Glyphosate on Growth of Chlorella,” Weed Science, vol. 29, Issue 1, Jan. 1981, pp. 5-7.
Roessler et al., “Genetic Engineering Approaches for Enhanced Production of Biodiesel Fuel from Microalgae,” ACS Symposium Series; American Chemical Society, 1994, pp. 255-270.
Endo et al. “Inactivation of Blasticidin S by Bacillus Cereus II. Isolation and Characterization of a Plasmid, pBSR 8, from Bacillus Cereus,” The Journal of Antibiotics 41 (2): 271-2589-2601.
Hallmann et al., “Genetic Engineering of the Multicellular Green Alga Volvox: A Modified and Multiplied Bacterial Antibiotic Resistance Gene as a Dominant Selectable Marker” The Plant Journal17(1): 99-109 (Jan. 1999).
Kindle et al. “Stable Nuclear Transformation of Chlamydomonas Using the Chlamydomonas Gene for Nitrate Reductase” The Journal of Cell Biology 109 (6, part 1 ): 2589-2601.
Prein et al. “A Novel Strategy for Constructing N-Terminal Chromosomal Fusions to Green Fluorescent Protein in the Yeast Saccharomyces cerevisiae” FEBS Letters 485 (2000) 29-34.
Schiedlmeier et al., “Nuclear Transformation of Volvox Carteri” Proceedings of the National Academy of Sciences USA 91 (11): 5080-5084 (May 1994).
Wendland et al. “PCR-Based Methods Facilitate Targeted Gene Manipulations and Cloning Procedures” Curr.Gen. (2003) 44:115-123.
Molnar et al., “Highly Specific Gene Silencing by Artificial MicroRNAs in the Unicellular Agla Chlamydomonas reinhardtii,” Plant Jour. ePub Jan. 17, 2009, vol. 58, No. 1, pp. 157-164 (Abstract Only).
Chen et al., “Conditional Production of a Functional Fish Growth Hormone in the Transgenic Line of Nannochloropsis oculata (Eustigmatophyceae),” J. Phycol. Jun. 2008, vol. 44, No. 3, pp. 768-776.
Nelson et al., “Targeted Disruption of NIT8 Gene in Chlamydomonas reinhardtii.” Mol. Cell. Bio. Oct. 1995, vol. 15, No. 10, pp. 5762-5769.
Kureshy et al., “Effect of Ozone Treatment on Cultures of Nannochloropsis oculata, Isochrysis galbana, and Chaetoceros gracilis,” Journal of the World Aquaculture Society, 1999, 30(4), pp. 473-480.
Genbank Accession No. U71602 (Nannochloropsis sp. Violaxanthing/chlorophyll a binding protein precursor (NANVCP) mRNA, 1998.
Sukenik et al. “Characterization of a Gene Encoding the Light-Harvesting Violaxanthin-Chlorophyll Protein of Nannochloropsis Sp. (Eustigmatophyceae),” Journal of Phycology, Jun. 2000; 36(3), pp. 563-570.
Abe et al., AG610981, Musmusculus molossinus DNA, 2004.
Kopczynski et al., C0268749, Drosophila melanogaster eDNA clone EK092604, 2004.
Csogor et al., “Light Distribution in a Novel Photobioreactor—Modelling for Optimization,” Journal of Applied Phycology, vol. 13, pp. 325-333.
Janssen et al., “Enclosed Outdoor Photobioreactors: Light Regime, Photosynthetic Efficiency, Scale-Up, and Future Prospects,” Biotechnology and Bioengineering, vol. 81, No. 2, pp. 193-210, Jan. 2003.
Zittelli et al., “Mass Cultivation of Nannochloropsis Sp. in Annular Reactors,” Journal of Applied Phycology, vol. 15, pp. 107-113, Mar. 2003.
Strzepek et al., “Photosynthetic Architecture Differs in Coastal and Oceanic Diatoms,” Nature, vol. 431, pp. 689-692, Oct. 2004.
Shi et al., “Analysis of Expressed Sequence Tags from the Marine Microalga Nannochloropsis Oculata (eustigmatophyceae),” Journal of Phycol, vol. 44, pp. 99-1 02, 2008.
Thiel et al., “Transformation of a Filamentous Cyanobacterium by Electroporation,” Journal of Bacteriology, Oct. 1989, vol. 171, No. 10, pp. 5743-5746.
Krienitz et al., “Nannochloropsis limnetica (Eustigmatophyceae), a new species of picoplankton from freshwater,” Phycologia, 2000, vol. 39, No. 3, Abstract.
Lee et al., “Isolation and Characterization of a Xanthophyll Aberrant Mutant of the Green Alga Nannochloropsis oculata,” Marine Biotechnology, 2006, vol. 8, pp. 238-245.
Sukenik et al., “Regulation of Fatty Acid Composition by Irradiance Level in the Eustigmatophyte Nannochloropsis,” Journal of Phycol., 1989, vol. 25, pp. 686-692.
Rocha et al., “Growth Aspects of the Marine Microalga Nannochlorpsis gaditana,” Biomolecular Engineering, 2003, vol. 20, pp. 237-242.
Macintyre et al., “Primary Production by Suspended and Benthic Microalgae in a Turbid Estuary: Time-Scales of Variability in San Antonio Bay, Texas,” Marine Ecology Progress Series, 1996, vol. 145, pp. 245-268.
Dunahay et al, “Manipulation of Microalgal Lipid Production Using Genetic Engineering,” Applied Biochemistry and Biotechnology, 1996, vol. 57/58/.
Witkowski et al., “Conversion of a B-Ketoacyl Synthase to a Malonyl Decarboxylase by Replacement of the Active-Site Cysteine with Glutamine,” Biochemistry, 1999, val. 38, 11643-11650.
Kisselev, “Polypeptide Release Factors in Prokaryotes and Eukaryotes: Same Function, Different Structure,” Structure, vol. 10, Jan. 2002.
Whisstock et al., “Predication of protein function from protein sequence and structure,” Q. Rev. Biophysics, 2003, vol. 36, pp. 307-340.
Broun et al., “Catalytic Plasticity of Fatty Acid Modification Enzymes Underlying Chemical Diversity of Plant Lipids,” Science, vol. 282, 1998.
Wishart et al , “A Single Mutation Converts a Novel Phosphotyrosine Binding Domain into a Dual-specificity Phosphatase,” J. Bioi. Chern. 1995, vol. 270(45), pp. 26782-26785.
Geng et al, “Construction of a System for the Stable Expression of Foreign Genes in Dunaliella Salina,” Acta Botanica Sinica 46(3): 342-346, 2004.
Chen et al., “Highly Efficient Expression of Rabbit Neutrophil Peptide-1 gene in Chlorella Ellipsoidea Cells,” Current Genetics 39(5-6): 365-370, 2001.
Suga et al., “Control by Osmolarity and Electric Field Strength of Electro-Induced Gene Transfer and Protein Release in Fission Yeast Cells,” Journal of Electrostatics 64(12): 796-801, 2006.
International Search Report dated Sep. 16, 2009 for Application No. PCT/US2009/004296, filed Jul. 24, 2009.
Written Opinion of the International Searching Authority dated Sep. 16, 2009 for Application No. PCT/US2009/004296, filed Jul. 24, 2009.
Office Action dated Nov. 14, 2012 in China Patent Application No. 200980138072.X, filed Jul. 24, 2009.
Official Action dated Jul. 10, 2012 in Mexico Patent Application No. MX/a/20111000934, filed Jul. 24, 2009.
Official Action dated Mar. 5, 2013 in Mexico Patent Application No. MX/a/2011/000934, filed Jul. 24, 2009.
Duarte et al., “Giyphosate {GP) Effects with Emphasis on Aquatic Organisms,” Colunbia Orinoquia, ISSN: 0121-3709, pp. 70-100, 2004.
Technical Card: Glyphosate, Document filed for the Pesticide Action Network and the Alternatives Thereof, for Latin America (RAP-AL)-Communications and Administration Office, Apr. 2008.
Department of Environment, Housing and Territorial Development Ministry, Resolution (1009), published Jun. 17, 2008.
International Search Report and Written Opinion of the International Searching Authority dated Oct. 30, 2009 for Application No. PCT/US2009/046656, filed Jun. 8, 2009.
International Search Report and Written Opinion of the International Searching Authority dated Aug. 12, 2009 for Application No. PCT/US2009/003819, filed Jun. 25, 2009.
International Search Report and Written Opinion of the International Searching Authority dated Dec. 20, 2010 for Application No. PCT/US2010/053265, filed Oct. 19, 2010.
Extended European Search Report dated Mar. 19, 2013 in European Patent Application 10825551.4, filed on Oct. 19, 2010.
Minoda et al., “Improvement of Culture Conditions and Evidence for Nuclear Transformation by Homologous Recombination in a Red Alga, Cyanidioschyzon merolae 10D,” Plant and Cell Physiology, vol. 45, No. 6, Jun. 2004, pp. 667-671.
Hallmann et al., “Gene Replacement by Homologous Recombination in the Multicellular Green Alga, Volvox carteri,” Proceedings of the National Academy of Sciences in the United States of America, vol. 94, No. 14, 1997, pp. 7469-7474.
Kilian et al., “High-efficiency homologous recombination in the oil-producing alga Nannochloropsis sp.,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, No. 52, Dec. 2001, pp. 21265-21269.
Extended European Search Report dated Oct. 19, 2011 in European Patent Application 09759628.2, filed on Jun. 8, 2009.
Hallmann, “Algal Transgenics and Biotechnology,” Transgenic Plant Journal, Global Science Books Ltd., GB, vol. 1, No. 1, Jan. 2007, pp. 81-98.
International Search Report and Written Opinion of the International Searching Authority dated Oct. 20, 2010 for Application No. PCT/US2010/001754, filed Jun. 16, 2010.
International Search Report and Written Opinion of the International Searching Authority dated Sep. 9, 2009 for Application No. PCT/US2009/046650, filed Jun. 8, 2009.
International Search Report and Written Opinion of the International Searching Authority dated Jun. 15, 2011 for Application No. PCT/US2010/042666, filed Jul. 20, 2010.
Pollock, “High Carbon Dioxide Requiring Mutants of Chlamydomonas Reinhardtll,” Created Dec. 2003, [online, retrieved Oct. 14, 2010] <http://etd.lsu.edu/docs/available/etd-0828103-114026/unrestricted/Pollock—dis.pdf>.
Drocourt: GenBank Accession No: X52869.1, created Jan. 3, 1995.
PAN: GenBank Accession No: EE1 09892.1, created Jun. 23, 2008.
PAN: GenBank Accession No: EE1 09907, created Jun. 23, 2008.
Henriquez et al.: GenBank Accession No: Q07CY9, created Oct. 31, 2006.
International Search Report and Written Opinion of the International Searching Authority dated Oct. 16, 2012 for Application No. PCT/US2012/035633, filed Apr. 27, 2012.
Yu et al., “Construction and characterization of a normalized cDNA library of Nannochloropsis oculata (Eustigmatophyceae),” Chinese Journal of Oceanology and Limnology, vol. 28, No. 4, pp. 802-807, 2010.
Lumbreras et al., “Efficient Foreign Gene Expression in Chlamydomonas Reinhardtii Mediated by an Endogenous Intron,” The Plant Journal, vol. 14, No. 4 Jan. 1, 1998, pp. 441-447, XP001150496, ISN: 0960-7412, DOI: 10, 1046/j.1365-313X. 1998.00 145.X.
Rose A.B., “Intron-Mediated Regulation of Gene Expression,” Current Topics in Microbiology and Immunology vol. 326, Jan. 1, 2008, pp. 277-290, XP009145370, ISSN: 0070-217X.
Rose A.B., “The Effect of Intron Location on Intron-Mediated Enhancement of Gene Expression in Arabidopsis,” The Plant Journal, vol. 40, No. 5, Dec. 1, 2004, pp. 744-751, XP55029911, ISSN: 0960-7412, DOI:10.1111/j. 1365-313X.2004.02247.
International Search Report and Written Opinion of the International Searching Authority dated Sep. 13, 2013 in Application No. PCT/US2013/038939 filed Apr. 30, 2013.
Notice on the First Office Action dated May 20, 2013 in Chinese Application No. 201080058106.7 filed Oct. 19, 2010.
Examination Report dated Feb. 20, 2013 in Australian Application No. 200927 4500 filed Jul. 24, 2009.
Examination Report dated Apr. 29, 2013 in European Application No. 09759628.2 filed Jun. 8, 2009.
Examination Report dated Aug. 29, 2013 in Australian Application No. 2009255947 filed Jun. 8, 2009.
Examination Report dated Sep. 19, 2013 in Australian Application No. 2010310765 filed Oct. 19, 2010.
Notice on the Second Office Action dated Sep. 24, 2013 in Chinese Application No. 200980138072.X filed Jul. 27 24, 2009.
Zuo-Xi Ruan et al., Effects of Acute Glyphosate Exposure on the Growth and Physiology of Nostoc Sphaeroides, an Edible Cyanobacterium of Paddy Rice Fields, Acta Hydrobiologica Sinica, Jul. 2008 vol. 32, No. 4.
Office Action dated Nov. 11, 2013 in Mexican Application No. MX/a/2011/000934 filed Jul. 24, 2009.
GenBank Acession No. ER498938 GI: 133929743 May 22, 2007.
Second Office Action dated Feb. 7, 2014 in Chinese Application No. 201080058106.7 filed Oct. 19, 2010.
Related Publications (1)
Number Date Country
20160053273 A1 Feb 2016 US
Provisional Applications (1)
Number Date Country
61480364 Apr 2011 US
Divisions (1)
Number Date Country
Parent 14328463 Jul 2014 US
Child 14880979 US
Continuations (1)
Number Date Country
Parent 13459215 Apr 2012 US
Child 14328463 US